Loading the COBO IP website…

News & Insights

Brazil and Uruguay Launch Collaborative Patent Examination Project

August 25, 2026

The Brazilian Patent and Trademark Office (BRPTO), on August 25, 2026, in its Official Gazette No. 2903, has officially launched a Collaborative Patent Examination Project with Uruguay’s Patent and Trademark Office (DNPI) under their 2026 Bilateral Cooperation Memorandum of Understanding. 

To qualify for this pilot, patent applications must meet three specific requirements: 

  • Technical Field: Pharmaceuticals (pharmaceutical chemicals and biopharmaceuticals), biotechnology, or natural products. 
  • Filing Route: National phase entries via the Patent Cooperation Treaty (PCT) with corresponding family counterparts at both BRPTO and DNPI. 
  • Entry Date: applications filed at BRPTO in 2021 or 2022. 

The initial set of applications selected for the project includes: 

BR Application No.  Applicant(s)  UY counterpart  PCT No. 
BR 112023015177-5  JOINT STOCK COMPANY BIOCAD   UY39621A  PCT/RU2022/000025 
BR 112023015909-1  PAIRWISE PLANTS SERVICES, INC. / MONSANTO TECHNOLOGY LLC  UY39631A  PCT/US2022/015893 
BR 112023016360-9  JANSSEN BIOTECH, INC.   UY39633A  PCT/US2022/016454 
BR 112023018003-1  JOINT STOCK COMPANY “BIOCAD”  UY39659A  PCT/RU2022/050073 
BR 112022025435-0  ASTRAZENECA AB  UY39296A  PCT/EP2021/067304 
BR 112023000406-3  ASTRAZENECA AB  UY39321A  PCT/IB2021/056177 
BR 112023003423-0  VERTEX PHARMACEUTICALS INCORPORATED   UY39395A  PCT/US2021/047754 
BR 112023016970-4  ENANTA PHARMACEUTICALS, INC.  UY39642A  PCT/US2022/017686 

 

The selected applications will be removed from the standard backlog queue and prioritized for expedited technical examination. The BRPTO will not issue preliminary office action for these cases. Participation strictly serves to advance the timeline; once technical examination begins, each application will follow BRPTO’s standard prosecution workflow. 

To learn more about the BRPTO’s Collaborative Patent Examination Projects, contact us at cobo@coboip.com. We will be pleased to assist you.